Pfizer and BioNTech start trials of new Omicron-specific jab
Pfizer and BioNTech have started clinical trials of a new Covid vaccine which targets the Omicron variant.
- Latest
- Trending
Pfizer and BioNTech have started clinical trials of a new Covid vaccine which targets the Omicron variant.
The CEO of COVID-19 vaccine maker BioNTech has a message for those who are worried about the Omicron variant of ...
German drugmaker BioNTech announced Monday it plans to develop an mRNA-based vaccine to prevent malaria, a life-threatening disease that impacts millions of ...
The first COVID-19 vaccines arrived in Canada on Sunday, Prime Minister Justin Trudeau said, and some Canadians are expected to ...
Saudi Arabia’s Food and Drug Authority announced on Thursday that it has approved registration of the Pfizer-BioNTech coronavirus vaccine in ...
Health Canada on Wednesday approved the COVID-19 vaccine from Pfizer Inc and BioNTech SE, clearing the way for shots to ...
Pfizer Inc and BioNTech could secure emergency U.S. and European authorization for their COVID-19 vaccine next month after final trial results showed ...
November 9 (CNBC) - U.S. pharmaceutical giant Pfizer and German biotech firm BioNTech announced Monday their coronavirus vaccine was more than 90% effective ...
